| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 55.382 | 59.544 | 53.423 | 365.647 | 481.845 | 359.515 |
| Total Income - EUR | - | - | 0 | 0 | 56.253 | 59.768 | 53.803 | 365.690 | 481.900 | 360.680 |
| Total Expenses - EUR | - | - | 1.986 | 513 | 84.486 | 90.700 | 52.017 | 236.946 | 474.606 | 599.818 |
| Gross Profit/Loss - EUR | - | - | -1.986 | -513 | -28.233 | -30.932 | 1.785 | 128.744 | 7.294 | -239.139 |
| Net Profit/Loss - EUR | - | - | -1.986 | -513 | -28.796 | -31.470 | 1.279 | 125.959 | 3.989 | -239.139 |
| Employees | - | - | 0 | 1 | 3 | 2 | 2 | 4 | 9 | 7 |
Check the financial reports for the company - Iclinique Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 9.191 | 9.557 | 18.984 | 17.309 | 16.304 | 21.533 | 981.758 | 965.310 |
| Current Assets | - | - | 15.052 | 11.898 | 30.830 | 53.275 | 55.213 | 206.436 | 117.538 | 143.027 |
| Inventories | - | - | 10.968 | 10.766 | 17.966 | 22.075 | 28.718 | 11.001 | 77.763 | 89.311 |
| Receivables | - | - | 1.001 | 983 | 1.391 | 1.566 | 960 | 6.136 | 21.930 | 18.197 |
| Cash | - | - | 3.084 | 149 | 11.473 | 29.634 | 25.535 | 189.298 | 17.845 | 35.519 |
| Shareholders Funds | - | - | -1.942 | -2.419 | -31.168 | -62.047 | -59.392 | 66.383 | 70.170 | -169.361 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 26.185 | 23.875 | 82.691 | 132.631 | 130.908 | 161.585 | 1.036.726 | 1.285.255 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Iclinique Srl